Aperio Group, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$4,687,000
+51.6%
201,670
+3.9%
0.02%
+46.7%
Q1 2018$3,091,000
-29.0%
194,166
-7.4%
0.02%
-31.8%
Q4 2017$4,356,000
+61.9%
209,621
+11.6%
0.02%
+46.7%
Q3 2017$2,691,000
+27.1%
187,803
+53.5%
0.02%
+15.4%
Q2 2017$2,117,000
+178.9%
122,379
+77.8%
0.01%
+160.0%
Q1 2017$759,000
+109.1%
68,837
+175.4%
0.01%
+66.7%
Q4 2016$363,000
-57.7%
24,995
-28.5%
0.00%
-50.0%
Q3 2016$858,000
+50.5%
34,959
+23.6%
0.01%
+50.0%
Q2 2016$570,000
-39.1%
28,291
-20.5%
0.00%
-50.0%
Q1 2016$936,000
-79.7%
35,592
-21.5%
0.01%
-81.0%
Q4 2015$4,612,000
-58.7%
45,368
-27.5%
0.04%
-63.2%
Q3 2015$11,156,000
-12.1%
62,541
+9.5%
0.11%
-13.0%
Q2 2015$12,686,000
+24.6%
57,105
+11.4%
0.13%
+14.9%
Q1 2015$10,178,000
+64.4%
51,242
+18.4%
0.11%
+50.0%
Q4 2014$6,192,000
+49.2%
43,268
+36.8%
0.08%
+35.7%
Q3 2014$4,149,000
+19.9%
31,620
+15.2%
0.06%
+12.0%
Q2 2014$3,460,000
-9.9%
27,437
-5.9%
0.05%
-7.4%
Q1 2014$3,842,000
+29.8%
29,147
+15.6%
0.05%
+17.4%
Q4 2013$2,960,000
+37.2%
25,209
+21.9%
0.05%
+9.5%
Q3 2013$2,157,000
+57.1%
20,677
+29.7%
0.04%
+27.3%
Q2 2013$1,373,00015,9470.03%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2015
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders